Search

Jeff William Natalini

Examiner (ID: 5556, Phone: (571)272-2266 , Office: P/2868 )

Most Active Art Unit
2858
Art Unit(s)
2818, 2896, 2868, 2831, 2858
Total Applications
1032
Issued Applications
816
Pending Applications
11
Abandoned Applications
214

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20321351 [patent_doc_number] => 20250333439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION [patent_app_type] => utility [patent_app_number] => 19/264681 [patent_app_country] => US [patent_app_date] => 2025-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19264681 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/264681
PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION Jul 8, 2025 Pending
Array ( [id] => 20492859 [patent_doc_number] => 12534722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Euglobulin-based method for determining the biological activity of defibrotide [patent_app_type] => utility [patent_app_number] => 19/173652 [patent_app_country] => US [patent_app_date] => 2025-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1329 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173652 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/173652
Euglobulin-based method for determining the biological activity of defibrotide Apr 7, 2025 Issued
Array ( [id] => 20480581 [patent_doc_number] => 12529052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => Euglobulin-based method for determining the biological activity of defibrotide [patent_app_type] => utility [patent_app_number] => 19/173657 [patent_app_country] => US [patent_app_date] => 2025-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1354 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173657 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/173657
Euglobulin-based method for determining the biological activity of defibrotide Apr 7, 2025 Issued
Array ( [id] => 20445586 [patent_doc_number] => 20260002303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-01 [patent_title] => PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/756409 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18756409 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/756409
PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF Jun 26, 2024 Pending
Array ( [id] => 19512086 [patent_doc_number] => 20240343772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => Fusion protein and its preparation method for intermediate polypeptide of Semaglutide [patent_app_type] => utility [patent_app_number] => 18/755691 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5432 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755691 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/755691
Fusion protein and its preparation method for intermediate polypeptide of Semaglutide Jun 26, 2024 Issued
Array ( [id] => 19601449 [patent_doc_number] => 20240392329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES [patent_app_type] => utility [patent_app_number] => 18/737619 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737619 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/737619
MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES Jun 6, 2024 Abandoned
Array ( [id] => 20330818 [patent_doc_number] => 12461089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Olfactory receptor involved in the perception of musk fragrance and the use thereof [patent_app_type] => utility [patent_app_number] => 18/406031 [patent_app_country] => US [patent_app_date] => 2024-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 17645 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406031 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/406031
Olfactory receptor involved in the perception of musk fragrance and the use thereof May 29, 2024 Issued
Array ( [id] => 19862606 [patent_doc_number] => 20250101392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => Enzyme Variants With Improved Ester Synthase Properties [patent_app_type] => utility [patent_app_number] => 18/662446 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662446
Enzyme variants with improved ester synthase properties May 12, 2024 Issued
Array ( [id] => 19543456 [patent_doc_number] => 20240360492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => COAGULATION AND FIBRINOLYSIS ASSAYS [patent_app_type] => utility [patent_app_number] => 18/657130 [patent_app_country] => US [patent_app_date] => 2024-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657130 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/657130
COAGULATION AND FIBRINOLYSIS ASSAYS May 6, 2024 Pending
Array ( [id] => 19745975 [patent_doc_number] => 20250034540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => BOTULINUM NEUROTOXIN BIOHYBRID [patent_app_type] => utility [patent_app_number] => 18/615341 [patent_app_country] => US [patent_app_date] => 2024-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15462 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615341 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/615341
BOTULINUM NEUROTOXIN BIOHYBRID Mar 24, 2024 Pending
Array ( [id] => 19432520 [patent_doc_number] => 20240301018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/584363 [patent_app_country] => US [patent_app_date] => 2024-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584363 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/584363
PD-1 homing endonuclease variants, compositions, and methods of use Feb 21, 2024 Issued
Array ( [id] => 19658830 [patent_doc_number] => 20240425895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => Cell-Free Protein Synthesis [patent_app_type] => utility [patent_app_number] => 18/441456 [patent_app_country] => US [patent_app_date] => 2024-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18441456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/441456
Cell-Free Protein Synthesis Feb 13, 2024 Pending
Array ( [id] => 19034269 [patent_doc_number] => 20240084084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => PROMOTER FOR YEAST [patent_app_type] => utility [patent_app_number] => 18/512485 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512485 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/512485
Promoter for yeast Nov 16, 2023 Issued
Array ( [id] => 19855552 [patent_doc_number] => 12258375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Mutant lysenin pores [patent_app_type] => utility [patent_app_number] => 18/504590 [patent_app_country] => US [patent_app_date] => 2023-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28377 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18504590 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/504590
Mutant lysenin pores Nov 7, 2023 Issued
Array ( [id] => 19281553 [patent_doc_number] => 20240218027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/503341 [patent_app_country] => US [patent_app_date] => 2023-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18503341 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/503341
NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF Nov 6, 2023 Abandoned
Array ( [id] => 19431067 [patent_doc_number] => 20240299565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => TOXIN-DERIVED DELIVERY CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 18/502473 [patent_app_country] => US [patent_app_date] => 2023-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502473 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/502473
TOXIN-DERIVED DELIVERY CONSTRUCTS Nov 5, 2023 Abandoned
Array ( [id] => 20578480 [patent_doc_number] => 12570722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Single alpha chain collagens [patent_app_type] => utility [patent_app_number] => 18/384018 [patent_app_country] => US [patent_app_date] => 2023-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 47 [patent_no_of_words] => 8465 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18384018 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/384018
Single alpha chain collagens Oct 25, 2023 Issued
Array ( [id] => 18955523 [patent_doc_number] => 20240043850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES [patent_app_type] => utility [patent_app_number] => 18/486403 [patent_app_country] => US [patent_app_date] => 2023-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18486403 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/486403
COMPOSITIONS AND METHODS FOR TYPE III POLYKETIDE PRODUCTION IN OLEAGINOUS YEAST SPECIES Oct 12, 2023 Abandoned
Array ( [id] => 20264375 [patent_doc_number] => 12435353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Biomarker assay for use in monitoring autism [patent_app_type] => utility [patent_app_number] => 18/470985 [patent_app_country] => US [patent_app_date] => 2023-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470985 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/470985
Biomarker assay for use in monitoring autism Sep 19, 2023 Issued
Array ( [id] => 20068887 [patent_doc_number] => 20250207109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE [patent_app_type] => utility [patent_app_number] => 18/709446 [patent_app_country] => US [patent_app_date] => 2023-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/709446
ENGINEERED SPLIT DHFR-BASED METHODS AND SYSTEMS FOR SELECTING CELLS THAT HAVE STABLY ACQUIRED A HETEROLOGOUS POLYNUCLEOTIDE Sep 19, 2023 Abandoned
Menu